Followers | 251 |
Posts | 50156 |
Boards Moderated | 47 |
Alias Born | 08/29/2007 |
Wednesday, March 06, 2024 1:59:24 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent PHAT News
- Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting • GlobeNewswire Inc. • 05/15/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:06:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:05:34 PM
- Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 12:00:00 PM
- Phathom Pharmaceuticals to Report First Quarter 2024 Financial Results and Provide Business Update on Thursday, May 9, 2024 • GlobeNewswire Inc. • 04/29/2024 12:00:00 PM
- Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid” • GlobeNewswire Inc. • 03/26/2024 12:00:05 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 09:01:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 01:06:53 PM
- Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/07/2024 01:00:50 PM
- Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024 • GlobeNewswire Inc. • 02/29/2024 01:00:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 01:05:31 PM
- Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients • GlobeNewswire Inc. • 02/13/2024 01:00:00 PM
- Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference • GlobeNewswire Inc. • 01/31/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 01:21:44 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:05:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 01:05:53 PM
- Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules Capital • GlobeNewswire Inc. • 12/14/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 01:05:52 PM
- Phathom Pharmaceuticals Announces FDA Acceptance for Filing of VOQUEZNA® (vonoprazan) Tablets New Drug Application for the Treatment of Heartburn Associated with Non-Erosive GERD • GlobeNewswire Inc. • 12/06/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 01:06:00 PM
- Phathom Pharmaceuticals Announces Commercial Availability of VOQUEZNA® (vonoprazan) Tablets, a Powerful First-In-Class PCAB for the Treatment of Erosive GERD and Relief of Associated Heartburn • GlobeNewswire Inc. • 11/28/2023 01:00:28 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/20/2023 05:15:34 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/09/2023 09:02:06 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 01:05:31 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM